Key result
Early cold exposure or β3-agonism protects male mice against diet-induced glucose intolerance and insulin resistance.
Hypothesis-generating for early β3-agonism in metabolic programming; human trials required before any clinical consideration.
. Here, we show that legacy effects of early physiological or pharmacological interventions driving adaptive adipose remodeling can mitigate maladaptive WAT remodeling and metabolic dysfunction when developing obesity later in life. Cold exposure or β3-adrenergic receptor (β3AR) agonism (CL316,243) induced thermogenic remodeling of WAT in male mice. After a prolonged recovery at room temperature, trained epididymal WAT reverted to an energy-storing state but retained a population of adipocytes resembling "metabolically flexible" visceral adipocytes found in human metabolically healthy obesity. The legacy of the antecedent treatment conferred lasting protection against glucose intolerance when later developing high fat diet (HFD)-induced obesity, with insulin sensitivity persisting for at least 20 weeks of overnutrition. This metabolic resilience was accompanied by healthy epididymal WAT expansion with reduced fibrosis and inflammation. Our findings demonstrate that short-term interventions, without genetic manipulation, can "train" adipose tissue, enhancing its long-term plasticity and conferring durable protection against future obesity-associated insulin resistance.
No takes yet. Share an insight, caveat, or question.
Morales et al. (2026) studied Obesity and metabolic dysfunction. Cold exposure or β3-adrenergic receptor (β3AR) agonism (CL316,243) was evaluated on Glucose intolerance and insulin sensitivity. Early cold exposure or β3-adrenergic receptor agonism in male mice conferred lasting protection against glucose intolerance and insulin resistance during subsequent high-fat diet-induced obesity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: